Try our corporate solution for free!
+1 (212) 419-5770
esther.shaulova@statista.com

Type 2 diabetes clinical trial success rates U.S. 2006-2015, by phase and indication

This statistic depicts the percentage of U.S. type 2 diabetes clinical trials for novel drugs that were successful in the period from 2006 to 2015, by phase and indication. Among diabetes NME/biologics just 4.8 percent were successful from phase I to approval.

Clinical trial success rates of novel type 2 diabetes drugs between 2006 and 2015, by phase and indication

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

$39 $59 per month *
in the first 12 months
33% Discount until October 31st
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

2019

Region

United States

Survey time period

2006 to 2015

Supplementary notes

NDA/BLA = new drug application/biologic license application
NME = new molecular entity

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract; Prices do not include sales tax.

Statistics on "Clinical trials"

Further Content: You might find this interesting as well

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.